Skip to main content

The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O’Brien SG, Druker BJ (2017) Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med 376(10):917–927. https://doi.org/10.1056/NEJMoa1609324

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. Dahlen T, Edgren G, Lambe M, Hoglund M, Bjorkholm M, Sandin F, Sjalander A, Richter J, Olsson-Stromberg U, Ohm L, Back M, Stenke L (2016) Cardiovascular events associated with use of tyrosine kinase inhibitors in chronic myeloid leukemia: a population-based cohort study. Ann Intern Med 165(3):161–166. https://doi.org/10.7326/m15-2306

    Article  PubMed  Google Scholar 

  3. Sukegawa M, Wang X, Nishioka C, Pan B, Xu K, Ohkawara H, Hamasaki Y, Mita M, Nakamura K, Okamoto M, Shimura H, Ohta M, Ikezoe T (2017) The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1beta in vascular endothelium in association with downregulation of miR-3p. Leuk Res 58:83–90. https://doi.org/10.1016/j.leukres.2017.05.0057

    CAS  Article  PubMed  Google Scholar 

  4. Breccia M, Molica M, Zacheo I, Serrao A, Alimena G (2015) Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment. Ann Hematol 94(3):393–397. https://doi.org/10.1007/s00277-014-2231-9

    CAS  Article  PubMed  Google Scholar 

  5. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331(7):417–424. https://doi.org/10.1056/nejm199408183310701

    CAS  Article  PubMed  Google Scholar 

  6. Biasucci Luigi M, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi Antonio G, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94(5):874–877. https://doi.org/10.1161/01.CIR.94.5.874

    Article  Google Scholar 

  7. Leitinger N (2003) Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 14(5):421–430

    CAS  Article  PubMed  Google Scholar 

  8. Van Tassell BW, Varma A, Salloum FN, Das A, Seropian IM, Toldo S, Smithson L, Hoke NN, Chau VQ, Robati R, Abbate A (2010) Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice. J Cardiovasc Pharmacol 55(2):117–122. https://doi.org/10.1097/FJC.0b013e3181c87e53

    CAS  Article  PubMed  Google Scholar 

  9. Liu SJ, Zhou W, Kennedy RH (1999) Suppression of beta-adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes. Am J Phys 276(1):H141–H148. https://doi.org/10.1152/ajpheart.1999.276.1.H141

    CAS  Article  Google Scholar 

  10. Ridker PM, Everett BM, Thuren T, JG MF, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, JJP K, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, PRF R, RPT T, Libby P, Glynn RJ, Group CT (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119–1131. https://doi.org/10.1056/NEJMoa1707914

    CAS  Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by Grant-in-Aid for Scientific Research

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takayuki Ikezoe.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mori, H., Sukegawa, M., Fukatsu, M. et al. The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study. Ann Hematol 99, 359–361 (2020). https://doi.org/10.1007/s00277-019-03896-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03896-4